Plocamium Holdings
Network Insights Directory Methodology Whitepaper Get Access

FDA

ORG Government / Pharmaceutical and Medical Device Regulation Momentum 60.2ML Momentum Score (0-100). Weighted composite of 9 features: mention velocity, article breadth, relationship density, deal context, recency, market cap, enrichment completeness, mention concentration, entity type. NORMALPSI regime classification. QUIET (<0.3): baseline activity. NORMAL (0.3-0.5): typical deal flow. ELEVATED (0.5-0.7): above-average signals. HIGH (0.7-0.85): significant activity. EXTREME (>0.85): exceptional signal concentration. Primary: Spectral Shift

FDA (6,900 employees, $6.5B budget) regulates 20% of US consumer spending across drugs, devices, and food. In the past week alone, approved first MCT8 deficiency treatment, launched advisory committee expansion initiative, investigated transnational counterfeit drug schemes, and signaled PMTA framework reforms.

As of 2026-10-13, Plocamium Signal Index scores FDA at 0.53 (NORMAL regime) with momentum 60.2 and 63 graph connections.

0.53
PSI ScorePlocamium Signal Index - composite z-score from 5 orthogonal signals: news frequency, targeted sentiment, graph centrality, regulatory filings, and clinical trial activity.
60.2
MomentumML Momentum Score (0-100). Weighted composite of 9 features including mention velocity, article breadth, deal context, and relationship density. Retrained weekly.
1%
ConfidenceSignal confidence - percentage of PSI sub-signals with sufficient data (30+ observations). Higher confidence means the PSI score is based on more complete data.
63
ConnectionsDegree centrality - number of unique entities this entity co-occurs with in news signals and articles. Higher = more connected in the intelligence network.
FDA is graph community structure is reorganizing around this entity — relationship patterns are changing (primary driver: Spectral Shift).
Connected Entities
Watch This Entity
PSI Intelligence
30-Day Trend
2026-09-13 2026-10-13 64 0 Degree Mentions
Signal Decomposition
Attention Cascade
-0.316
Narrative Drift
0.000
Spectral Shift
966.823
Sentiment-Momentum Divergence
0.000
Source Concentration
0.728
Signal
FDA is graph community structure is reorganizing around this entity — relationship patterns are changing (primary driver: Spectral Shift).
Driver
Ranked #326 of 1266 in Government — in line with sector peers. PSI down 0.68 from yesterday (0.94 -> 0.27).
Action
Baseline conditions. Continue standard monitoring cadence.
Peer Comparison
326 of 1266
Sector Rank
+0.50
Peer Z-Score
74%
Sector Percentile
Network Analysis
63 Degree Centrality
Ego Network (top connections)
White House (weight 89.0)PlocamiumAI (weight 74.0)HHS (weight 50.0)United States (weight 43.0)AstraZeneca (weight 40.0)WASHINGTON (weight 39.0)Dr. (weight 34.0)Eli Lilly (weight 33.0) White HousePlocamiumAIHHSUnited StatesAstraZenecaWASHINGTONDr.Eli Lilly FDA (degree 63) FDA
Centrality History
2026-09-13 2026-10-13 64 0 Degree Mentions
EntityWeight StatusFirst Seen
White House 89 STABLE
PlocamiumAI 74 NEW
HHS 50 STABLE
United States 43 STABLE
AstraZeneca 40 NEW
WASHINGTON 39 STABLE
Dr. 34 STABLE
Eli Lilly 33 NEW
China 33 STABLE
Robert F. Kennedy Jr. 30 NEW
Americans 25 NEW
Senate 23 STABLE
AP 21 STABLE
CMS 19 STABLE
DOJ 18 STRENGTHENED
Europe 17 STABLE
Reuters 17 STABLE
Trump administration 16 STABLE
California 15 STABLE
CDC 15 NEW
Merck 14 STABLE
Novartis 14 NEW
Texas 12 STABLE
President 12 STABLE
United Kingdom 10 STABLE
CEO 10 STABLE
Bloomberg 10 STABLE
Canada 9 STABLE
Mexico 9 STABLE
Republican 8 STABLE
Article Coverage (0)
DateLaneTitle
No Plocamium-authored coverage yet. This entity surfaces in upstream signals (news, filings, trials) but has not yet been a primary subject of a published article. Watch this entity to be alerted when one is published.

Request Access

Full PSI intelligence, network analysis, EDGAR filings, and predicted links require an access token.

Data as of 2026-10-13 ← Intelligence Network